Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > CR going up!!!

<< Previous

Bullboard Posts

Next >>

Comment by Eoganachton Feb 01, 2021 10:42am

247 Views

Post# 32435933

RE:RE:CR going up!!!

That's what it looks like. The 45% CR would be the percentage of CR patients from the 9 patients who have received or will receive a 180 day assessment. If 13 and 14 are CR then we'll be at 67% CR of those patients. Things look really great going forward.

fredgoodwinson wrote: Is it correct that the 9 patients are arrived at by taking 5 withdrawn from the original 12 to leave 7 and then adding Patients 13 & 14?

If so the 2 'to be determined' will be the only ones to have received the correct full dosing so might await their outcomes with some optimism.

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec